Inventor
ROUSH WILLIAM
US13 patents
⚠️ This page may combine multiple inventors who share the name “ROUSH WILLIAM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
6 patentsUS11724992B2Aug 15, 2023
Compounds and compositions for treating conditions associated with NLRP activity
NOVARTIS AG1 citations71
US11203579B2Dec 21, 2021
Compounds and compositions for treating conditions associated with NLRP activity
NOVARTIS AG2 citations71
US12421223B2Sep 23, 2025
Compounds and compositions for treating conditions associated with NLRP activity
NOVARTIS AG0 citations62
US12084424B2Sep 10, 2024
Compounds and compositions for treating conditions associated with NLRP activity
NOVARTIS AG0 citations61
US11370763B2Jun 28, 2022
Compounds and compositions for treating conditions associated with NLRP activity
NOVARTIS AG1 citations61
US12134611B2Nov 5, 2024
Compounds and compositions for treating conditions associated with NLRP activity
NOVARTIS AG0 citations51
MILLENNIUM PHARM INC
5 patentsUS6794516B2Sep 21, 2004
Synthesis of clasto-lactacystin β-lactone and analogs thereof
MILLENNIUM PHARM INC70 citations96
US6566553B2May 20, 2003
Synthesis of clasto-lactacystin β-lactone and analogs thereof
MILLENNIUM PHARM INC48 citations96
US6294560B1Sep 25, 2001
Synthesis of clasto-lactacystin β-lactone and analogs thereof
MILLENNIUM PHARM INC75 citations96
US6133308AOct 17, 2000
Synthesis of clasto-lactacystin beta-lactone and analogs thereof
MILLENNIUM PHARM INC78 citations96
US6849743B2Feb 1, 2005
Synthesis of clasto-lactacystin β-lactone and analogs thereof
MILLENNIUM PHARM INC71 citations95